Corinne Layne Stuart, DO
Interventional Pain Medicine · Bridgeport, WVNPI 1417177742
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,678 of the $8,349 with a category attached, or 68.0%. 9 manufacturers reported payments, led by Boston Scientific at 36.4% of the total. Reporting peaked in 2021 at $4,412 and has fallen 96.1% since, to $174 in 2025.
Across 57 payments — averaging $146.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$3K
- Relievant Medsystems, Inc.$828
- Nevro Corp.$677
- Curonix LLC$667
- Abbott$276
- plus $316 from 3 others
What the payments were for
- Travel & lodging$5,67868%
- Food & beverage$2,67132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $3,037 |
| Medtronic(2 entities) | 16 | $2,548 |
| Relievant Medsystems, Inc. | 6 | $828 |
| Nevro Corp. | 12 | $677 |
| Curonix LLC | 6 | $667 |
| Abbott | 2 | $276 |
| SPR Therapeutics, Inc | 1 | $161 |
| Pacira Pharmaceuticals Incorporated | 1 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $54 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,875
- SUPERION$1,559
- Intracept$1,451
- VERTIFLEX SUPERION$1,407
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$505
- Senza$376
- Omnia$233
- Proclaim DRG IPG$200
- SPRINT PNS System$161
- INCEPTIV$143
- Iovera$102
How this compares
Too few interventional pain medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 12 | $5,633 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 153 | $3,666 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 92 | $2,085 |
| Oxycodone Hcl | 93 | $1,599 |
| Fentanyl | 16 | $1,023 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $694 |
| Gabapentin | 44 | $285 |
| Methadone Hcl | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Bridgeport
- Timothy DeerCharleston$3.4M
- Christopher KimCharleston$108K
- Rudy MalayilHuntington$104K
- Andrew ThymiusBeckley$9K
- Raymond GreaserWheeling$9K
- Stephanie leWeirton$9K
- Luay MradParkersburg$8K
- Anuj ShahCharleston$7K
- George van OstenMartinsburg$145
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.